证券记录 · 已归档季度
BAX
Baxter International Inc. · Healthcare · Medical - Instruments & Supplies
19被追踪持有人
-1Δ持有人
263.48M持有股份
$7.98B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.0% ·
股份流向 +2.7% ·
净新建仓位 -5.3%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | -1 | 390.14M | $8.32B | +8 | −10 |
| Q1 2026 | 141 | -12 | 367.10M | $6.16B | +4 | −17 |
| Q4 2025 | 152 | +2 | 422.38M | $8.07B | +4 | −1 |
| Q3 2025 | 21 | 0 | 287.33M | $6.54B | +1 | −2 |
| Q2 2025 | 19 | -1 | 263.48M | $7.98B | n/a | −1 |
| Q1 2025 | 17 | 0 | 122.55M | $4.20B | +1 | −1 |
| Q4 2024 | 17 | -1 | 116.71M | $3.41B | +1 | −2 |
| Q3 2024 | 17 | -1 | 90.14M | $3.42B | n/a | −1 |
| Q2 2024 | 18 | n/a | 78.00M | $2.61B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 67.73M | n/a | $2.05B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 2 | The Vanguard Group ✦ (被动) | 62.19M | n/a | $1.88B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Dodge & Cox ✦ | 52.12M | +1.3% | $1.58B | 0.9% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 21.94M | +0.8% | $667.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 21.96M | +8.1% | $665.02M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 12.88M | +2.6% | $388.42M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Harris Associates (Oakmark) ✦ | 9.35M | +3.8% | $283.07M | 0.5% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (被动) | 5.47M | +18.7% | $165.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 4.07M | n/a | $123.20M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Point72 Asset Management ✦ | 2.25M | +704.1% | $68.18M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 1.38M | +323.9% | $41.84M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 1.06M | +59.1% | $32.20M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 385.69K | +39.9% | $11.68M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 333.94K | -59.7% | $10.11M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | GAMCO Investors ✦ | 198.45K | +5.2% | $6.01M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Wellington Management ✦ | 97.33K | +2.9% | $2.95M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | AQR Capital Management ✦ | 33.05K | -56.1% | $1.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 18 | Bridgewater Associates ✦ | 16.94K | -22.1% | $512,943 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Tweedy, Browne ✦ | 9.77K | -0.6% | $295,836 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $2.51M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 655 持有人, 526.17M 股份, $8.60B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Jun 05
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据